Ciencias de la Salud
Domaine de connaissance
![Foto de Ciencias de la Salud](/img/noimage.png)
![Foto de Philipp University of Marburg](/img/noimage_org.png)
Philipp University of Marburg
Marburgo, AlemaniaPublications en collaboration avec des chercheurs de Philipp University of Marburg (27)
2024
-
G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits
Nature communications, Vol. 15, Núm. 1, pp. 4307
-
PsyCog: A computerised mini battery for assessing cognition in psychosis
Schizophrenia Research: Cognition, Vol. 37
-
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 5, pp. 994-1004.e10
2023
2022
-
Correction to: Training During the COVID-19 Lockdown: Knowledge, Beliefs, and Practices of 12,526 Athletes from 142 Countries and Six Continents (Sports Medicine, (2022), 52, 4, (933-948), 10.1007/s40279-021-01573-z)
Sports Medicine
-
How to Succeed as an Athlete: What We Know, What We Need to Know
International Journal of Sports Physiology and Performance
-
Training During the COVID-19 Lockdown: Knowledge, Beliefs, and Practices of 12,526 Athletes from 142 Countries and Six Continents
Sports Medicine, Vol. 52, Núm. 4, pp. 933-948
2021
-
Editorial: The Immunological Implications of the Hygiene Hypothesis
Frontiers in Immunology
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2018
-
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study
HPB, Vol. 20, Núm. 3, pp. 251-259
2017
-
Magnetothermal genetic deep brain stimulation of motor behaviors in awake, freely moving mice
eLife, Vol. 6
-
POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer
Oncotarget, Vol. 8, Núm. 16, pp. 26732-26743
2016
-
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy
Movement Disorders, Vol. 31, Núm. 5, pp. 742-747
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
-
Model Driven Optimization of Magnetic Anisotropy of Exchange-Coupled Core-Shell Ferrite Nanoparticles for Maximal Hysteretic Loss
Chemistry of Materials, Vol. 27, Núm. 21, pp. 7380-7387
2014
-
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Movement Disorders, Vol. 29, Núm. 4, pp. 470-478
-
Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
Cell Death and Disease, Vol. 5, Núm. 3